TEVA Earnings Teva Pharmaceutical Industries Ltd
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–20 of 20
| Q1 2026 | 2026-03-31 | 0.31 | 2026-04-29 | 10-Q |
| FY 2025 | 2025-12-31 | 1.21 | 2026-02-03 | 10-K |
| Q3 2025 | 2025-09-30 | 0.80 | 2025-11-05 | 10-Q |
| Q2 2025 | 2025-06-30 | 0.43 | 2025-07-30 | 10-Q |
| Q1 2026 | 2025-03-31 | 0.18 | 2026-04-29 | 10-Q |
| FY 2025 | 2024-12-31 | -1.45 | 2026-02-03 | 10-K |
| Q3 2025 | 2024-09-30 | -1.26 | 2025-11-05 | 10-Q |
| Q2 2025 | 2024-06-30 | -0.87 | 2025-07-30 | 10-Q |
| Q1 2025 | 2024-03-31 | -0.12 | 2025-05-07 | 10-Q |
| FY 2025 | 2023-12-31 | -0.50 | 2026-02-03 | 10-K |
| Q3 2024 | 2023-09-30 | -0.91 | 2024-11-06 | 10-Q |
| Q2 2024 | 2023-06-30 | -0.98 | 2024-07-31 | 10-Q |
| Q1 2024 | 2023-03-31 | -0.20 | 2024-05-08 | 10-Q |
| FY 2024 | 2022-12-31 | -2.20 | 2025-02-05 | 10-K |
| FY 2023 | 2022-09-30 | 0.05 | 2024-02-12 | 10-K |
| FY 2023 | 2022-06-30 | -0.23 | 2024-02-12 | 10-K |
| Q1 2023 | 2022-03-31 | -0.86 | 2023-05-10 | 10-Q |
| FY 2023 | 2021-12-31 | 0.38 | 2024-02-12 | 10-K |
| Q3 2022 | 2021-09-30 | 0.52 | 2022-11-03 | 10-Q |
| Q2 2022 | 2021-06-30 | 0.26 | 2022-07-27 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.